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Abstract
One of the substantial changes in dentistry is the development of implant science. Along 
with the development of applications, implant science practitioners will face an inevitable 
challenge, which is how to deal with such problems. Recently conducted researches are 
more concentrated on surgical and prosthetic techniques, while the treatment for peri-
implant diseases is still incomplete. Therefore, the aim of this review research is to provide 
a broad and descriptive overview on peri-implant diseases and to suggest the related 
treatments. Scientifi c articles were collected by electronic searching through EMBASE 
and Medline, and since controlled clinical trials were limited in this fi eld, no limitation was 
imposed on the evaluated articles. Moreover, review articles and meta-analysis were used. 
For implants that bone resorption has aﬀ ected <50% of the implant length, the evaluation 
is thoroughly recommended. Regarding cases with a range of <2 mm, the treatment 
plan will be more inclined towards non-surgical methods and should be treated by Peri-
implant mucositis. If the bone resorption is >2 mm, surgical methods are proved to be 
more eﬀ ective and in the cases which has extended >50% of the implant length, it is better 
to remove the implant. By increasing the range of annual dental implant, peri-implant 
diseases have become a serious challenge in this fi eld. The proposed treatment plan will 
be a manual for dentists regarding on how to deal with implant problems; although further 
researches are required to approve the proposed protocols.
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Introduction
The success of an implant treatment is approved through various 
studies;[1-4] however, further evaluation is needed on how to treat 
peri-implant diseases.
One of the confi rmed causes of dental implant failure is 
bacterial plaque along with extensive loading.[5] Peri-implant 
diseases include non-specifi c infl ammatory reactions that occur 
in host tissues;[6-9] while the cases of infl ammation in soft tissues 
are known as peri-implant mucositis, which is often considered 
a reversible reaction.
Clinical characteristics of peri-implant mucositis include 
bleeding when being probed, peri-implant colitis, increase in probe 
depth (often as false pocket), or erythema, and redness of the implant 
that surrounds tissues.[10] It must be noted that symptoms are not 
necessarily limited to these cases. Moreover, when the infl ammatory 
lesion strikes the bone, it is called peri-implant.[11] Peri-implant is an 
irreversible process and bone resorption in radiography, bleeding, 
pus discharge during probe, increased pocket depth, ache, or fi stula 
are among its characteristics.[12]
A loose implant is considered as a “failed implant;”[12] while a 
“failing implant” is usually a progressive bone resorption with no 
looseness. It is a matter of the utmost importance to pay attention 
to practical diﬀ erences of these two expressions. Dental implants 
may fail in various phases:
• Early failing: Occurs when the absence of initial 
osseointegration is due to the inability of reaching the primary 
bone to implant contact. Factors that can be suggested in this 
case include early loading, surgical trauma, or incomplete/
inappropriate healing response (such as patients with 
immune suppression, AIDS).[13,14]
• Late failure: Happens after the initial integration of 
physiologic remodeling and loading. Bacterial infection and 
excessive loading are among the main factors in late failure.[15] 
Failure due to the fi rst year of loading is not prevalent.[16]
Ailing implant, also defi ned as peri-implant biological 
problems, is referred to the limited diseases of peri-implant’s soft 
tissue that do not aﬀ ect the supporting bone tissues. On the other 
hand, losing non-progressive connections and no looseness are 
its characteristics.[17,18]
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Peri-implant infl ammatory processes are roughly similar to 
what happens around the tooth, except in the cases that peri-
implant infections are initially less resistant to destruction 
due to the existence of the periodontal ligament.[19,20] In other 
words, unlike the presence of fi bers that are vertically placed 
around the tooth, peri-implant fi bers are mostly parallel 
because of the absence of cementum. Moreover, the blood 
supply in peri-implant has been reduced in comparison with 
tooth.[20] The aim of the present review article is to evaluate 
the causes of peri-implant diseases and its related treatment 
approaches.
Materials and Methods
By electronic searching through EMBASE and Medline, the 
scientifi c articles were collected and since controlled clinical 
trials were limited in this fi eld, no limitation has been imposed 
on the evaluated articles. Moreover, review articles and meta-
analysis were used. Words like mucositis peri-implant, treatment, 
peri-implantitis, and implant complications were used while 
searching for articles.
Results
The prevalence of peri-implant diseases was often suggested by 
retrospective studies.[21-23] Fransson et al.[24] indicated that >90% 
of peri-implant tissues have some infl ammatory response. They 
have also reported 28% prevalence regarding the mentioned 
diseases.
Roos-Jansåker et al.[21] stated the prevalence of peri-implant 
mucositis as 48%, whereas 6.6% of implants have had the peri-
implant. In general, defi ning the prevalence of peri-implant 
diseases is slightly diﬃ  cult due to the application of various 
protocols, diﬀ erent follow-up periods, various implant systems, 
designs, and practical diameters. On the other hand, related 
information on implant placement area in terms of bone width 
and height or its position in the mouth cavity is not fi xed in 
various studies.
It is said that the primary cause of infl ammation in peri-implant 
tissues is the resultant infection of anaerobic bacteria.[25,26] Initial 
evolution of periodontal pathogens in the biofi lm of implant 
levels is reported in edentulous people[27] and it is similar to 
what has been identifi ed in tooth.[28-31] Periodontal pathogens 
could be colonized in implant level 14 days after mouth cavity 
exposition and a complicated subgingival microbial biomass will 
shape within 28 days after the implant exposition.[32] Sato et al.[33] 
has clearly shown the presence of most periodontal pathogens 
in bone resorption cases compared with peri-implant mucositis. 
Peri- implant infl ammation could lead to bone resorption, and if it 
is not managed properly, it could cause implant loss. Furthermore, 
they illustrated in several cases that the existence of >5 mm 
remnant pockets after the treatment of active periodontal disease 
can increase peri-implant and implant loss.[34] This issue underlines 
the signifi cance of accurate diagnosis in the initial phases of the 
disease and the necessity of appropriate and timely intervention.
Managing and treating peri-implant diseases
Controlling peri-implant diseases is a diﬃ  cult and unpredictable 
process. One of the most important factors in their treatment is 
to evaluate implant looseness. The implant must be removed 
immediately if it comes loose during clinical check, after 
examining the possibility of abutment screw or prosthesis 
looseness.[15,18]
This type of decision-making is in line with Pisa implant health 
test criterion, in which three groups are introduced as implants 
status (compromised success, failure, and satisfactory).[12] In this 
classifi cation, failure is considered as a loose implant. In general, 
looseness of the implant is the indicator of weakened bone-to-
implant contact (BIC); therefore, a dentist must consider the 
situation as a criterion and instruction for deciding to whether 
keep the implant or not.
Treating peri-implant mucositis
When the implant is not loose, the next step is to identify the 
presence or range of bone resorption. If no resorption was 
detected, the diagnosis of peri-implant mucositis is highly 
probable, which is called Ailing implant.[18] On the other hand, 
if the bone resorption has occurred, we would be facing a 
peri-implant, known as failing implant. Peri-implant diseases, 
including peri-implant mucositis are infectious illnesses caused 
by Gram-negative pathogens in periodontal.[35-37]
Similar to the natural tooth, preventing the growth of 
biofi lm and removing it from the implant must be the fi rst phase 
in preserving the health of peri-implant soft tissue. Hence, 
treatment methods for peri-implant mucositis has nonsurgical 
basis and initially consist of mucosa and submucosa scaling. 
Synthetic treatments, including mechanical debridement and 
the application of non-microbial factors (such as chlorhexidine 
and essential oils), have been studied with caution to prevent 
damaging hemidesmosome joints at sulcus base and satisfactory 
results were obtained.[38-40] However, most studies have proposed 
the use of antiseptics, the eﬀ ects of topical antibiotic agents, 
and irrigation with antibiotics as supplementary treatments in 
mechanical debridement.[41-43] The important point is that, studies 
have reported some signifi cant advantages regarding the use of 
such agents in reducing index plaque. Schär et al.[44] indicated that 
the eﬀ ect of nonsurgical treatments by photodynamic therapy 
is similar to topical antibiotic; however, removing the whole 
infl ammation has not been seen in treatment methods.
Various surgical and synthetic methods were employed for 
surviving and treating ailing implant, which include debridement, 
decontamination of implant, and regenerative methods.[45-52] 
Nevertheless, determining the best treatment method is not 
possible due to the variety of clinical conditions.
Peri-implant treatment
Peri-implant is considered as one of the main concerns in 
implant treatment. This obstacle is about peri-implant bone 
resorption with no looseness. For successful treatment of this 
problem, dentists must realize the range of bone resorption as 
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their fi rst step. Since the common two-dimensional radiographs 
have low sensitivity and cannot accurately identify the initial 
lesions,[53,54] implants prognostic evaluations are limited through 
these diagnostic methods. On the other hand, the treatment 
of implants with bone resorption is unpredictable in any way 
because the mechanical loading of these implants could endanger 
the long-lasting success.[55] In the cases of bone resorption 
extending to >50% of the length, it is highly recommended to 
remove the implant and after the reconstruction of hard and 
soft tissues and obtaining acceptable results, it could be replaced 
in the area. Although these conditions are treatable by guided 
bone regeneration, concerning the conducted researches in this 
fi eld to achieve this osseointegration is extremely diﬃ  cult and 
unpredictable.[56]
For implants with <50% bone resorption, the case must 
be evaluated accurately. If the resorption is <2 mm, design is 
administered by nonsurgical methods, which is similar to peri-
implant mucositis treatment. Nonsurgical treatments have been 
evaluated by diﬀ erent strategies.[57-65] Mechanical debridement, 
regardless of the technique type, is not individually useful 
in removing the lesion and complete halting of peri-implant 
diseases.[57] In other words, conducted studies on dogs, in which 
suture was the cause of disease, has shown favorable results 
in the form of reduction in periodontal pathogens,[58] as well 
as improvement in clinical parameters such as probe depth 
reduction, adhesion improvement, bleeding on probe,[59] and 
plaque index due to mechanical treatment.
Synthetic treatments along with systemic antimicrobial 
(amoxicillin, metronidazole, tetracycline and clindamycin)[60,61] 
or topical antimicrobials[62,63] (tetracycline fi bers, minocycline 
microspheres, and chlorhexidine gel) have shown a general 
reduction in number of pathogens and improvement of clinical 
parameters (index plaque, pocket depth, adhesion limit, and 
bleeding on probing [BOP]). Laser is suggested as an alternative 
to mechanical debridement[65] and encouraging results has 
been reported; however, there is limited information on 
functionality, useful dosage, and probable eﬀ ects on the bone, 
which indicates further research is needed. Consequently, it is 
worth mentioning that the obtained improvements is limited 
to clinical parameters and as published in various numbers 
of researches, not a single case has received the treatment 
completely. Accordingly, we cannot treat an advanced peri-
implant through only nonsurgical method, expecting successful 
and predictable results. Exception can be made when bone 
resorption is limited and healing is facilitated by nonsurgical 
methods. Surgical methods are recommended when the bone 
resorption is >2 mm but has aﬀ ected less than half of the implant 
length. Serino and Turri[66] has stated that the success of surgical 
treatments in peri-implant diseases is related to the range of the 
initial resorption. The employed peri-implant surgical methods 
is similar to the applied methods in periodontitis and the basic 
principles, including the removal of pathogens, are used in all 
the mentioned issues.[25] If the aim of treatment is to preserve 
the bone, pushing the fl ap aside, similar to fl ap with apical 
position is performable.[59] Regarding cases in which bone 
contour modifi cation is considered, bone surgical methods are 
recommended. In surgical methods, the basic treating principles 
are the decontamination of infected implants.[25] Nonetheless, 
retaining the integrity of the implant is a considerable challenge 
for clinicians. Various methods have been introduced for 
implants debridement. Favorable results were achieved in a 
study that chemical agents, such as metronidazole gel have 
been used as a fl ap.[59] Although the range of the obtained bone 
remodeling is minimum, evidences were presented to prove 
the functionality of abrasive pumices by electric toothbrushes 
with rotational motion for the purpose of decontamination.[67] 
The comparison of various debridement and decontamination 
methods, including Air-power abrasive, citric acid, normal 
saline, gas impregnated with chlorhexidine, or the combination 
of these methods, did not illustrate a signifi cant diﬀ erence in 
terms of bone regeneration and reintegration.[68] According to 
a case report, using fl ap surgery (along with decontamination 
by hydrogen peroxide) with systemic antibiotic have caused 
an improvement in clinical parameter (BOP) in the long-
term and also halted the disease.[69] Irrespective of implant 
decontamination methods (the common mechanical methods, 
chemical agents, Air-abrasive, laser, saline, and ultrasonic), 
fl ap surgery with implant decontamination is a treatment 
which improves and subsidies infl ammation, reconstructs the 
appropriate bone contour around implant, and halts the bone 
resorption. Bone respective surgeries around the contaminated 
implant (such as replacing implant levels, implantoplasty) can 
be performed along with respective surgeries for the contour 
modifi cation and bone anatomy. The obtained results indicated 
that, implantoplasty has the potential for more improvement 
compared to debridement with prescribing antibiotics.[49]
To provide remission and achieve health status in 
surrounding implant tissues, reintegration is vital, and to 
reach that in a failing implant, various generative methods 
have been employed and diﬀ erent graft materials have been 
used to increase the range of BIC. Graft materials including 
xenografts, allografts, and alloplasts with/without membrane 
were used for this purpose.[46,47,51,70] These studies have shown 
the improvement of clinical and radiographic parameters as the 
reduction of probe depth and fi lling of the lesion. There is no 
strong evidence in this fi eld to support the usage of membrane, 
while in cases that membrane is used, its exposition is reported 
as a relatively common problem.[67] Some studies proposed 
resorbable membranes to prevent exposure eﬀ ects and reduce 
re-surgeries for removing non-resorbable membranes.[51,52] 
Currently, despite the lack of consensus on the privilege of a 
certain membrane, this is highly recommended. Dentists must 
carefully examine the clinical condition of patients and adopt the 
ideal treatment strategy based on the proposed methods.
There are various methods to prevent the outbreak of disease 
around an implant, especially in patients with periodontal records, 
sensitive to peri-implant diseases, and more susceptible to 
colonization of pathogens.[71-75] However, as long as the patient is in 
a good state of health and attends the follow-up sessions regularly, 
the issue is not a defi nite prescription for dental implants.[76,77] 
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It must be noted that peri-implant soft tissue infl ammation is 
possible, even in patients with no periodontal record as well. 
Accurate elimination and the removal of remnant infection is 
a prerequisite treatment, since the remaining teeth can act as a 
source of periodontal and bacterial pathogens. Early pathologic 
detection is a signifi cant factor in preventing disease progress and 
long retention of dental implant health. It is worth mentioning that 
the depth of peri-implant probing is not considered as a reliable 
method to check the health of a peri-implant[78] and radiographic 
evaluations are important, as well. Therefore, peri-implant 
probing and probe depth enhancement are related to adhesion 
loss and bone resorption,[79,80] which could be a suitable method 
for evaluating the adhesion limit. It must be noted that, the 
accuracy of evaluation methods is a limitation and also, bitewing 
and periapical radiographs are helpful in this fi eld.[81]
Consequently, a decision tree has been defi ned to control 
peri-implant diseases to be used as a manual.[82-84] In order to 
treat and evaluate the peri-implant problems, long-term and 
periodical clinical and radiograph evaluations, along with their 
comparison to the criteria are needed. Since peri-implantitis and 
periodontitis are not curable diseases and relapse is probable, 
longtime retention periods in patients to control and prevent is 
the matter of the utmost importance.
Conclusion
By the increase in number of annual implant replacements, 
peri-implant diseases have become a challenge. The proposed 
treatment in this project will be a manual for dentists to confront 
the issue. To confi rm the provided protocols, further studies are 
required in this fi eld.
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